Autoimmune Cytopenia Associated With Chronic Lymphocytic Leukemia Clinical Trial
Official title:
Efficacy of BCR Inhibitors in the Treatment of Autoimmune Cytopenias Associated With Chronic Lymphocytic Leukemia (CLL): A Retrospective Analysis of the French Innovative Leukemia Organization (FILO)
Efficacy of BCR Inhibitors in the Treatment of Autoimmune Cytopenias Associated with Chronic Lymphocytic Leukemia (CLL): A Retrospective Analysis of the French Innovative Leukemia Organization (FILO)
The investigators of the study propose a card of data collection, validated by the scientific
council of the group FILO.
The data to be collected are entered on an e-CRF made available to the investigators on a
secure site.
The main data collected are as follows
- anonymized demographic data
- Clinical and Biological Data of CLL at Diagnosis
- Previous treatments of LLC and CAI
- clinical and laboratory data at the time of initiation of BCRi treatment
- response to treatment with BCRi
- tolerance to BCRi treatment
- Progression under treatment with BCRi
- Recent news
;